Further work will also be required to determine how metformin mediates suppression of SNAT2, which may be related to observations that metformin acts on the v-ATPase–Ragulator complex [91] and might account for other observations that BCAA and glutamine oxidation are suppressed by metformin in tumour cells [92]. Here, SLC38A2 is linked to neoplasm.